1. Home
  2. KLIC vs ANIP Comparison

KLIC vs ANIP Comparison

Compare KLIC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLIC
  • ANIP
  • Stock Information
  • Founded
  • KLIC 1951
  • ANIP 2001
  • Country
  • KLIC United States
  • ANIP United States
  • Employees
  • KLIC N/A
  • ANIP N/A
  • Industry
  • KLIC Semiconductors
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLIC Technology
  • ANIP Health Care
  • Exchange
  • KLIC Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • KLIC 2.0B
  • ANIP 2.0B
  • IPO Year
  • KLIC N/A
  • ANIP N/A
  • Fundamental
  • Price
  • KLIC $35.79
  • ANIP $81.70
  • Analyst Decision
  • KLIC Buy
  • ANIP Strong Buy
  • Analyst Count
  • KLIC 4
  • ANIP 7
  • Target Price
  • KLIC $45.00
  • ANIP $99.29
  • AVG Volume (30 Days)
  • KLIC 368.0K
  • ANIP 473.0K
  • Earning Date
  • KLIC 11-19-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • KLIC 2.29%
  • ANIP N/A
  • EPS Growth
  • KLIC N/A
  • ANIP N/A
  • EPS
  • KLIC 0.11
  • ANIP 1.67
  • Revenue
  • KLIC $657,842,000.00
  • ANIP $826,880,000.00
  • Revenue This Year
  • KLIC N/A
  • ANIP $40.23
  • Revenue Next Year
  • KLIC $18.61
  • ANIP $9.65
  • P/E Ratio
  • KLIC $325.32
  • ANIP $48.40
  • Revenue Growth
  • KLIC N/A
  • ANIP 48.87
  • 52 Week Low
  • KLIC $26.63
  • ANIP $52.50
  • 52 Week High
  • KLIC $52.08
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • KLIC 34.59
  • ANIP 25.18
  • Support Level
  • KLIC $38.32
  • ANIP $79.39
  • Resistance Level
  • KLIC $39.41
  • ANIP $85.17
  • Average True Range (ATR)
  • KLIC 1.13
  • ANIP 4.39
  • MACD
  • KLIC -0.41
  • ANIP -1.18
  • Stochastic Oscillator
  • KLIC 13.07
  • ANIP 13.16

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: